glucose control fasting and 2 hour postprandial blood glucose [clinicaltrials_resource:f3601bcf0ee188acfbf3695427460aba]
patients received glyburide initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
glucose control fasting and 2 hour postprandial blood glucose [clinicaltrials_resource:f3601bcf0ee188acfbf3695427460aba]
patients received glyburide initial dose of 500 mg PO BID. Increased as necessary to a maximum dose of 2000 mg QD to control blood glucose
Bio2RDF identifier
f3601bcf0ee188acfbf3695427460aba
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f3601bcf0ee188acfbf3695427460aba
measure [clinicaltrials_vocabulary:measure]
glucose control
time frame [clinicaltrials_vocabulary:time-frame]
fasting and 2 hour postprandial blood glucose
description
patients received glyburide in ...... mg QD to control blood glucose
identifier
clinicaltrials_resource:f3601bcf0ee188acfbf3695427460aba
title
glucose control fasting and 2 hour postprandial blood glucose
@en
type
label
glucose control fasting and 2 ...... 01bcf0ee188acfbf3695427460aba]
@en